The do’s and don’ts of digital transformation for healthcare CIOs
Done right, digital transformation in healthcare drives productivity, satisfaction, quality of care, and reimbursement—but it can be easy to get wrong.
Cloud Pharmaceuticals eyeing $10 million round
It also projects $5 million in revenue this year.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In silico approach to develop cancer drugs: Cloud Pharmaceuticals and University of Florida team up
Could be the beginnings of a win to the in silico approach to drug development: Cloud Pharmaceuticals is working with University of Florida to develop new cancer drugs that are conceived on a computer. The Research Triangle Park-based startup will share intellectual property with the university, and the two will jointly fund 10 research projects. So far, […]
Cloud Pharmaceuticals raising $20M for its “in silico” approach to drug development
We’re all plenty familiar with in-vivo and in-vitro, but Cloud Pharmaceuticals is taking the “in-silico“ approach to drug development. Its “inverse design” platform uses cloud supercomputing to cherry pick and formulate molecules that will work as new medications – cutting out much of the early lab expenses by conducting the earliest drug discovery processes virtually. The Research Triangle […]